665 results on '"van Laar, Teus"'
Search Results
2. A retrospective study of the MDS criteria for prodromal Parkinson’s disease in the general population
3. Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”
4. Objective clinical registration of tremor, bradykinesia, and rigidity during awake stereotactic neurosurgery: a scoping review
5. Tools and criteria to select patients with advanced Parkinson’s disease for device-aided therapies: a narrative review
6. Acute effects of adaptive Deep Brain Stimulation in Parkinson’s disease
7. Timely referral for device-aided therapy in Parkinson's disease. Development of a screening tool
8. The Effectiveness of Inpatient Rehabilitation in Parkinson’s Disease: A Systematic Review of Recent Studies
9. Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients
10. Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
11. Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET study
12. Postural and gait symptoms in de novo Parkinson's disease patients correlate with cholinergic white matter pathology
13. Short-latency afferent inhibition as a biomarker of cholinergic degeneration compared to PET imaging in Parkinson's disease
14. Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypes
15. Enhanced arm swing improves Parkinsonian gait with EEG power modulations resembling healthy gait
16. Cholinergic systems, attentional-motor integration, and cognitive control in Parkinson's disease
17. Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study
18. Multisensory mechanisms of gait and balance in Parkinson's disease: an integrative review.
19. Impaired facial emotion recognition in relation to social behaviours in de novo Parkinson's disease.
20. Long‐Term Follow‐Up of the LEAP Study: Early Versus Delayed Levodopa in Early Parkinson's Disease.
21. Systematic analysis of PINK1 variants of unknown significance shows intact mitophagy function for most variants
22. Electrical stimulation of the nucleus basalis of meynert: a systematic review of preclinical and clinical data
23. Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts
24. Retinal layers in Parkinson's disease: A meta-analysis of spectral-domain optical coherence tomography studies
25. Accuracy of Intraoperative Computed Tomography in Deep Brain Stimulation—A Prospective Noninferiority Study
26. Reduced Thickness of the Retina in de novo Parkinson's Disease Shows A Distinct Pattern, Different from Glaucoma.
27. Deep brain stimulation in dystonia: The added value of neuropsychological assessments.
28. Reading Difficulties in Parkinson’s Disease: A Stepped Care Model for Neurovisual Rehabilitation
29. Cholinergic innervation topography in GBA-associated de novo Parkinson’s disease patients
30. The Relevance of Intraoperative Clinical and Accelerometric Measurements for Thalamotomy Outcome
31. Cholinesterase Inhibitors for Treatment of Psychotic Symptoms in Alzheimer Disease and Parkinson Disease
32. Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
33. Substituting the Target After Unsatisfactory Outcome of Deep Brain Stimulation in Advanced Parkinson’s Disease: Cases From the NSTAPS Trial and Systematic Review of the Literature
34. Deep Brain Stimulation for Essential Tremor: A Comparison of Targets
35. Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: A retrospective long-term follow-up study
36. Infusion Therapies in the Treatment of Parkinson’s Disease
37. Impaired facial emotion recognition in relation to social behaviours in de novo Parkinson's disease
38. A Novel Accelerometry Method to Perioperatively Quantify Essential Tremor Based on Fahn–Tolosa–Marin Criteria
39. Diepe hersenstimulatie bij de ziekte van Parkinson
40. Dorsal subthalamic nucleus targeting in deep brain stimulation: microelectrode recording versus 7-Tesla connectivity.
41. Cognitive and psychiatric outcome 3 years after globus pallidus pars interna or subthalamic nucleus deep brain stimulation for Parkinson's disease
42. Unmet needs in Parkinson's disease: New horizons in a changing landscape
43. The need for non-oral therapy in Parkinson's disease; a potential role for apomorphine
44. Understanding the role of the Parkinson's disease nurse specialist in the delivery of apomorphine therapy
45. Supine MDS-UPDRS-III Assessment: An Explorative Study
46. Combined multidisciplinary in/outpatient rehabilitation delays definite nursing home admission in advanced Parkinson’s disease patients
47. Prevalence and nature of self-reported visual complaints in people with Parkinson’s disease—Outcome of the Screening Visual Complaints questionnaire
48. Visual Hallucinations in Psychosis: The Curious Absence of the Primary Visual Cortex
49. The Intraoperative Microlesion Effect Positively Correlates With the Short-Term Clinical Effect of Deep Brain Stimulation in Parkinson's Disease
50. Parkinson's disease, visual hallucinations and apomorphine: A review of the available evidence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.